Sublingual Immunotherapy for Pediatric Allergic Rhinitis: The Clinical Evidence

Overview

Journal World J Clin Pediatr

Publisher Baishideng Publishing Group

Date 2016 Feb 11

PMID 26862501

Citations 5

Authors

Dimitri Poddighe

Amelia Licari

Silvia Caimmi

Gian Luigi Marseglia

Affiliations

Soon will be listed here.

Abstract

Allergic rhinitis is estimated to affect 10%-20% of pediatric population and it is caused by the IgE-sensitization to environmental allergens, most importantly grass pollens and house dust mites. Allergic rhinitis can influence patient's daily activity severely and may precede the development of asthma, especially if it is not diagnosed and treated correctly. In addition to subcutaneous immunotherapy, sublingual immunotherapy (SLIT) represents the only treatment being potentially able to cure allergic respiratory diseases, by modulating the immune system activity. This review clearly summarizes and analyzes the available randomized, double-blinded, placebo-controlled trials, which aimed at evaluating the effectiveness and the safety of grass pollen and house dust mite SLIT for the specific treatment of pediatric allergic rhinitis. Our analysis demonstrates the good evidence supporting the efficacy of SLIT for allergic rhinitis to grass pollens in children, whereas trials regarding pediatric allergic rhinitis to house dust mites present lower quality, although several studies supported its usefulness.

Citing Articles

Efficacy and Safety of Guizhi Decoction AssociatedFormulas for Allergic Rhinitis: A Systematic Review.

Yang S, Fu Q, Deng H, Wu J, Zhang Q, Wang L Evid Based Complement Alternat Med. 2021; 2021:3548740.

PMID: 33519942 PMC: 7817259. DOI: 10.1155/2021/3548740.

Gui-zhi decoction for allergic rhinitis: A protocol for systematic review and meta analysis.

Zou B, Zhang W, Cai Y, Zhang F, Wang C Medicine (Baltimore). 2020; 99(38):e21931.

PMID: 32957312 PMC: 7505288. DOI: 10.1097/MD.0000000000021931.

Novel therapeutic targets for allergic airway disease in children.

Giallongo A, Parisi G, Licari A, Pulvirenti G, Cuppari C, Salpietro C Drugs Context. 2019; 8:212590.

PMID: 31391855 PMC: 6668505. DOI: 10.7573/dic.212590.

Ma-Huang-Fu-Zi-Xi-Xin Decoction for Allergic Rhinitis: A Systematic Review.

Zhong J, Lai D, Zheng Y, Li G Evid Based Complement Alternat Med. 2018; 2018:8132798.

PMID: 29636787 PMC: 5832110. DOI: 10.1155/2018/8132798.

Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management.

Poddighe D, Gelardi M, Licari A, Miraglia Del Giudice M, Marseglia G World J Methodol. 2017; 6(4):200-213.

PMID: 28074172 PMC: 5183989. DOI: 10.5662/wjm.v6.i4.200.

References

Hebert J, Blaiss M, Waserman S, Kim H, Creticos P, Maloney J . The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children. Allergy Asthma Clin Immunol. 2015; 10(1):53. PMC: 4326370. DOI: 10.1186/1710-1492-10-53. View

Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner D . Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. J Allergy Clin Immunol. 2011; 127(1):64-71, 71.e1-4. DOI: 10.1016/j.jaci.2010.11.034. View

Yonekura S, Okamoto Y, Sakurai D, Horiguchi S, Hanazawa T, Nakano A . Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children. Allergol Int. 2010; 59(4):381-8. DOI: 10.2332/allergolint.10-OA-0200. View

Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G . Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol. 2006; 97(2):141-8. DOI: 10.1016/S1081-1206(10)60004-X. View

Pleskovic N, Bartholow A, Skoner D . Sublingual immunotherapy in children: the recent experiences. Curr Opin Allergy Clin Immunol. 2014; 14(6):582-90. DOI: 10.1097/ACI.0000000000000112. View

Morjaria J, Caruso M, Rosalia E, Russo C, Polosa R . Preventing progression of allergic rhinitis to asthma. Curr Allergy Asthma Rep. 2014; 14(2):412. DOI: 10.1007/s11882-013-0412-6. View

Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L . Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol. 2009; 123(1):167-173.e7. DOI: 10.1016/j.jaci.2008.10.044. View

Lee J, Choi Y, Kim M, Han D, Rhee C, Lee C . Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2011; 107(1):79-84. DOI: 10.1016/j.anai.2011.03.012. View

Nuhoglu Y, Ozumut S, Ozdemir C, Ozdemir M, Nuhoglu C, Erguven M . Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period. J Investig Allergol Clin Immunol. 2007; 17(6):375-8. View

10.

Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T . Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy. 2004; 59(5):498-504. DOI: 10.1111/j.1398-9995.2004.00457.x. View

11.

Marcucci F, Sensi L, Di Cara G, Salvatori S, Bernini M, Pecora S . Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy. Pediatr Allergy Immunol. 2005; 16(6):519-26. DOI: 10.1111/j.1399-3038.2005.00301.x. View

12.

Harbour R, Miller J . A new system for grading recommendations in evidence based guidelines. BMJ. 2001; 323(7308):334-6. PMC: 1120936. DOI: 10.1136/bmj.323.7308.334. View

13.

Eberle P, Brueck H, Gall R, Hadler M, Sieber J, Karagiannis E . An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents. Pediatr Allergy Immunol. 2014; 25(8):760-6. DOI: 10.1111/pai.12298. View

14.

Marseglia G, Incorvaia C, La Rosa M, Frati F, Marcucci F . Sublingual immunotherapy in children: facts and needs. Ital J Pediatr. 2009; 35(1):31. PMC: 2772839. DOI: 10.1186/1824-7288-35-31. View

15.

Han D, Choi Y, Lee J, Kim D, Kim J, Lee C . Clinical efficacy of sublingual immunotherapy in pediatric patients with allergic rhinitis sensitized to house dust mites: comparison to adult patients. Acta Otolaryngol. 2012; 132 Suppl 1:S88-93. DOI: 10.3109/00016489.2012.660732. View

16.

Barberi S, Villa M, Pajno G, La Penna F, Barreto M, Cardelli P . Immune response to sublingual immunotherapy in children allergic to mites. J Biol Regul Homeost Agents. 2012; 25(4):627-34. View

17.

Roberts G, Xatzipsalti M, Borrego L, Custovic A, Halken S, Hellings P . Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013; 68(9):1102-16. DOI: 10.1111/all.12235. View

18.

Aydogan M, Eifan A, Keles S, Akkoc T, Nursoy M, Bahceciler N . Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Respir Med. 2013; 107(9):1322-9. DOI: 10.1016/j.rmed.2013.06.021. View

19.

Wuthrich B, Bucher C, Jorg W, Bircher A, Eng P, Schneider Y . Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Investig Allergol Clin Immunol. 2003; 13(3):145-8. View

20.

Rolinck-Werninghaus C, Wolf H, Liebke C, Baars J, Lange J, Kopp M . A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy. 2004; 59(12):1285-93. DOI: 10.1111/j.1398-9995.2004.00627.x. View